UCL-led trial shows adding niraparib to standard therapy reduces tumour growth risk in men with advanced prostate cancer by up to 37%, with greater effect in specific genetic subgroups.
The University of Applied Sciences in Nordhausen and Pfalzklinikum explain why rural areas have advantages over cities in developing healthy communities
The European Federation of Pharmaceutical Industries and Associations (EFPIA) explain how SAFE-T DIKI is advancing research into drug-induced kidney injury
Carrie Bourassa, Scientific Director, CIHR-IAPH discusses the issue of poor health among Indigenous communities and says research is the key to tackling it
Canadian Cancer Society’s Dr Rob Nuttall and Shawn Chirrey explain how fighting against breast cancer requires ongoing support for research and screening
Ageing and age-related morbidity are unavoidable, but research to understand and alleviate age-related health issues is the need of the hour to ascertain healthy-ageing. Dr. Nirmal Robinson, Principal Investigator at the CECAD Research Centre discusses.
Dr. Lisa Halvorson, U.S. National Institutes of Health discusses the importance of gynaecologic research to develop new treatments and keep women healthy